EMA Pharmacovigilance Panel Makes Moves on Cancer, MS Drugs

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee declared the chemotherapy drug docetaxel safe to use after it concluded that there is no evidence of changes in the known risk of intestinal inflammation after treatment.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor